MedX Health Corp (TSXV:MDX)
Canada · Delayed Price · Currency is CAD 0.0450
0.00 (0.00%)
At close: Sep 10, 2026
MedX Health Financials Overview
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 0.57 | 0.47 | 0.49 | 0.46 | 0.51 | 0.56 |
Revenue Growth | 19.14% | -3.36% | 7.37% | -10.68% | -9.32% | 6.23% |
Gross Profit Gross Profit Growth | -0.01 | -0.05 | 0.19 | 0.19 | 0.24 | 0.27 |
Operating Income Operating Income Growth | -4.28 | -4.29 | -2.3 | -3.03 | -3.87 | -4.56 |
Net Income Net Income Growth | -6.19 | -6.29 | -3.65 | -4.58 | -5.13 | -5.32 |
Earnings Per Share EPS Growth | -0.02 | -0.02 | -0.01 | -0.02 | -0.03 | -0.03 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Canada Canada Growth | 0.33 | 0.27 | 0.35 | 0.3 | 0.19 | 0.25 |
United States United States Growth | 0.18 | 0.17 | 0.12 | 0.04 | 0.07 | 0.16 |
Europe/UK Europe/UK Growth | 0.04 | 0.03 | 0 | 0.09 | 0.21 | 0.12 |
Rest of The World Rest of The World Growth | 0.03 | 0.01 | 0.01 | 0.03 | 0.03 | 0.03 |
Total Total Growth | 0.57 | 0.47 | 0.49 | 0.46 | 0.51 | 0.56 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 0.02 | 0.02 | 0.16 | 0.14 | 0.14 | 0.11 |
Total Debt Total Debt Growth | 8.69 | 7.97 | 7.01 | 5.84 | 5 | 2.58 |
Net Cash (Debt) Net Cash Growth | -8.67 | -7.96 | -6.86 | -5.71 | -4.86 | -2.47 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.03 | -0.03 | -0.03 | -0.03 | -0.03 | -0.01 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -3.78 | -3.73 | -2.51 | -3.42 | -2.8 | -4.52 |
Capital Expenditures CapEx Growth | -0 | -0 | - | - | - | -0.02 |
Free Cash Flow Free Cash Flow Growth | -3.78 | -3.73 | -2.51 | -3.42 | -2.8 | -4.53 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | -2.37% | -11.51% | 39.66% | 40.70% | 46.99% | 48.54% |
Operating Margin | -750.46% | -906.90% | -470.44% | -663.99% | -757.61% | -810.29% |
Pretax Margin | -1086.06% | -1329.15% | -745.96% | -1004.31% | -1005.41% | -945.40% |
Profit Margin | -1086.06% | -1329.15% | -745.96% | -1004.31% | -1005.41% | -945.40% |
FCF Margin | -664.09% | -788.56% | -512.70% | -750.32% | -548.53% | -805.04% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 13.00 | 13.00 | 13.00 | 13.00 | 13.00 |
PS Ratio | 25.90 | 38.11 | 33.10 | 34.46 | 12.60 | 26.10 |